logo-large
  • Browse Categories

Publications by authors named "Yuriy Lebed"

Claim this Profile
R
RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial.
Olga Holubovska, Pavlo Babich, Alla Mironenko, Jens Milde, Yuriy Lebed

Adv Respir Med· May 2024


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial.
Olha Holubovska, Denisa Bojkova, Stefano Elli, Marco Bechtel, David Boltz, Yuriy Lebed

medRxiv· January 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pure purr virtual reality technology: measuring heart rate variability and anxiety levels in healthy volunteers affected by moderate stress.
Sam Aganov, Eugene Nayshtetik, Vasyl Nagibin, Yuriy Lebed

Arch Med Sci· February 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: